Flora growth corp. applauds reported historic dea move to reschedule cannabis

Fort lauderdale, florida--(newsfile corp. - may 1, 2024) - flora growth corp. (nasdaq: flgc) ("flora" or the "company"), a consumer-packaged goods leader and pharmaceutical distributor, is applauding the reported historic move by the u.s. drug enforcement administration ("dea") to reclassify cannabis from its list of schedule i drugs to schedule iii, following a recommendation from the federal health and human services department ("hhs"). "this expected rescheduling would come shortly after germany's legalization of recreational cannabis becoming effective earlier in april.
FLGC Ratings Summary
FLGC Quant Ranking